Sector consensus Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.390 USD | -0.88% |
|
-2.02% | +23.27% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 12.93 | +278.17% | 15 | ||||||
| 669.22 | +16.51% | 23 | ||||||
| 198.91 | +4.43% | 22 | ||||||
| 413.05 | +33.69% | 27 | ||||||
| 229.63 | +10.28% | 19 | ||||||
| 2,56,128.97 | +43.73% | 24 | ||||||
| 257.16 | +10.07% | 18 | ||||||
| 445.58 | -18.43% | 12 | ||||||
| 104.86 | +21.47% | 22 | ||||||
| 71.03 | +3.06% | 14 | ||||||
| 180.81 | +7.17% | 16 | ||||||
| 138.56 | +9.28% | 6 | ||||||
| 218 | -4.67% | 15 | ||||||
| 69.08 | -2.16% | 12 | ||||||
| 66.06 | +9.94% | 16 | ||||||
| 130.53 | -2.26% | 12 | ||||||
| 123.76 | +3.79% | 21 | ||||||
| 50.19 | -9.11% | 16 | ||||||
| 619.11 | +91.11% | 18 | ||||||
| 120.54 | -14.42% | 13 | ||||||
| Average | 13,012.4 | +24.58% | 17 | ||||||
| Weighted average by Cap. | 19,885.75 | +13.90% | 19 |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
